Invesco
FLNA

Invesco’s Filana Therapeutics FLNA Stock Holding History

Invesco’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.6K Buy
31,130
+13,010
+72% +$26.8K ﹤0.01% 3688
2025
Q4 		$35.9K Buy
+18,120
New +$58K ﹤0.01% 3729
2025
Q2 		– Sell
-13,117
Closed -$19.7K – 3856
2025
Q1 		$19.7K Sell
13,117
-2,291
-15% -$5.78K ﹤0.01% 3744
2024
Q4 		$36.4K Sell
15,408
-290,882
-95% -$5.11M ﹤0.01% 3718
2024
Q3 		$9.01M Buy
306,290
+291,519
+1,974% +$6.71M ﹤0.01% 1895
2024
Q2 		$182K Buy
14,771
+554
+4% +$11.7K ﹤0.01% 3647
2024
Q1 		$288K Sell
14,217
-61,275
-81% -$1.41M ﹤0.01% 3539
2023
Q4 		$1.7M Buy
75,492
+58,679
+349% +$1.24M ﹤0.01% 2677
2023
Q3 		$280K Sell
16,813
-357
-2% -$7.08K ﹤0.01% 3478
2023
Q2 		$421K Sell
17,170
-278,452
-94% -$6.71M ﹤0.01% 3338
2023
Q1 		$7.13M Sell
295,622
-124,668
-30% -$3.45M ﹤0.01% 2042
2022
Q4 		$12.4M Buy
420,290
+164,203
+64% +$5.9M ﹤0.01% 1693
2022
Q3 		$10.7M Buy
256,087
+240,355
+1,528% +$6.49M ﹤0.01% 1746
2022
Q2 		$442K Sell
15,732
-489
-3% -$12.3K ﹤0.01% 3388
2022
Q1 		$602K Sell
16,221
-342
-2% -$14.5K ﹤0.01% 3301
2021
Q4 		$723K Sell
16,563
-1,578
-9% -$82.8K ﹤0.01% 3238
2021
Q3 		$1.13M Sell
18,141
-154,923
-90% -$12.9M ﹤0.01% 3049
2021
Q2 		$14.8M Buy
173,064
+153,686
+793% +$8.23M ﹤0.01% 1806
2021
Q1 		$871K Buy
19,378
+6,921
+56% +$272K ﹤0.01% 3101
2020
Q4 		$85K Buy
+12,457
New +$111K ﹤0.01% 3662
2014
Q4 		– Sell
-2,900
Closed -$79K – 4100
2014
Q3 		$79K Sell
2,900
-4,583
-61% -$139K ﹤0.01% 3901
2014
Q2 		$301K Buy
7,483
+312
+4% +$11.5K ﹤0.01% 3538
2014
Q1 		$277K Buy
+7,171
New +$253K ﹤0.01% 3623

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Invesco's FLNA Position: Q1 2026 in Review

Invesco increased its Filana Therapeutics (FLNA) stake by 72% in Q1 2026, buying an estimated $26.8K and bringing the position to 31,130 shares worth $52.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3688.

Invesco first reported a position in FLNA in Q1 2014 and has held it in 23 quarters since. The position peaked at $14.8M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Invesco held 31,130 shares of Filana Therapeutics worth $52.6K as of Q1 2026.
  • Invesco bought 13,010 Filana Therapeutics shares in Q1 2026, an estimated $26.8K.
  • Filana Therapeutics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3688 holding.
  • Invesco first reported a position in Filana Therapeutics in Q1 2014 and has held it in 23 quarters since.
  • Invesco's Filana Therapeutics position peaked at $14.8M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.